App-Quantinova.ai

Anticoagulation Prophylaxis With Enoxaparin For Patients With Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy

Hassan Sibai - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Asparaginase

Phase II Study Of Combination Of Hyper-CVAD With Ponatinib In Front Line Therapy Of Patients (pts) With Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)

Elias Jabbour - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Cyclophosphamide

A Randomized Comparison Of Maintenance Therapy With Subcutaneous Rituximab For 2 Years Versus Until Progression In Patients With Indolent Non-Hodgkins Lymphoma: Interim Safety Data From The Mabcute Study

Simon Rule - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Rituximab

German Hodgkin Study Group Phase I Trial Of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) For Older Hodgkin Lymphoma Patients

Boris Boll - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Lenalidomide

Pomalidomide In MPNassociated Myelofibrosis With Cytopenia: Results Of The Mpnsg 01-09 Study

Richard F. Schlenk - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Albyl-E

Thrombosis History and Relationship With Low Thrombocytosis, Leukocytosis, and Other Characteristics At Diagnosis In 977 Essential Thrombocythemia Patients: A Multivariate Analysis Of The Registro Italiano Trombocitemie (RIT)

Luigi Gugliotta - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Correlation Of Longitudinal Blood Counts With Thromboembolic Complications In WHO 2008 Defined Prefibrotic Primary Myelofibrosis

Veronika Buxhofer-Ausch - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparable Outcomes With Bortezomib-Cyclophosphamide-Dexamethasone (VCD) and Bortezomib-Lenalidomide-Dexamethasone (VRD) For Initial Treatment Of Newly Diagnosed Multiple Myeloma (MM)

Shaji Kumar - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Cyclophosphamide

Long-Term Survival With Cybord Induction Therapy In Newly Diagnosed Multiple Myeloma

Craig B. Reeder - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Cyclophosphamide

Leopard: A Phase II Study Of Post Autologous Stem Cell Transplantation (ASCT) Maintenance Lenalidomide and Prednisolone For Myeloma (MM), Incorporating Minimal Residual Disease (MRD) Assessments

Anna Kalff - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Lenalidomide

Burden Of Illness and Treatment Patterns For Patients With Multiple Myeloma In a US Integrated Healthcare System

Nazia Rashid - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Lenalidomide

Combination Of Lenalidomide, Dexamethasone and Cyclophosphamide as Treatment For The First Relapse Of Multiple Myeloma: Efficacy, Toxicity and Occurance Of Thyroid Abnormalities

Marta Krejci - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Cyclophosphamide

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients a Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dexamethasone

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

Gesine Bug - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Panobinostat

Bleeding Incidence Among Patients With Venous Thromboembolism: A Large US Insurance Database Analysis

Xianchen Liu - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Validation Of Medical Inpatient Venous Thrombosis Risk Assessment (MITH) Score

Damon E Houghton - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Methadone hydrochloride

Identifying Bleeding Risk In Medical Inpatients

John P. Winters III - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Methadone hydrochloride

Readmission Rates Due To Venous Thromboembolism In Cancer Patients After Abdominopelvic Surgery

Christine Klimowicz White - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

Incidence Rate Of Venous Thromboembolism (VTE) and Utilization Of a VTE Prophylaxis Order Set Module In Hospitalized Patients With Leukemia

Michael H. Kroll - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

Pre-Surgical Levels Of Circulating Cell-Derived Microparticles Are Most Significant Predictors Of Transfusion Requirement In Coronary Artery Bypass Graft Surgery

Wenche Jy - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Filters

7277 Abstracts